US Pharma MarketingRevisiting Pharma’s tariff reality
Revisiting Pharma’s tariff reality is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Fierce Pharma’s Fraiser Kansteiner catches up with KPMG’s Chris Young to discuss the latest pharma tariff developments and how Big Pharma and small- to mid-sized drugmakers are responding.
Source: FiercePharma